BS PAS 157-2015 PDF

BS PAS 157-2015 PDF

Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide

$43.18 $86.36 -50%
Publisher
isbn 9780580898679
Product Code: BS PAS 157
Stock In Stock
Published: 04/30/2015
Number of Pages: 32
File Size: 1 file, 320 KB

Available Options

Product Description

Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide

Scope: This PAS gives guidance on the evaluation of materials of biological origin used in the production of cell-based medicinal products for human use; including those gene therapy products whereby the cells form part of the final drug product. This PAS also includes guidance on identifying, assessing and controlling risks to patients associated with materials of biological origin. This PAS covers the evaluation of all materials of biological origin that come into contact with the cellular active substance. This PAS focuses primarily on materials of human and animal origin and their potential impurities and contaminants. However, reagents derived from diverse biological sources including plants, insects and marine organisms are also used in the development of cell- based medicinal products. Therefore the fundamental principles of risk management also apply for these materials. This PAS also covers legislation for cell-based medicinal products and is intended for developers who wish to undertake clinical trials and/or license products in both the EU and the US. This PAS does not cover the selection, assessment or control of cellular active substances, nor the starting materials as defined in Directive 2001/83/EC [1] and excipients. However, it is anticipated that these are still covered by general risk management procedures. This PAS does not cover biological materials that are used in the development of any other biological medicinal product. This PAS is applicable for product developers at all stages of development; however maximum benefits can be gained by the implementation of recommendations in this PAS in the early stages of development. This PAS is intended for use by organizations and individuals with an interest in the development of cell-based medicinal products for clinical applications. 2 Terms, definitions and abbreviations 2.1 Terms and definitions For the purposes of this PAS the terms and definitions given in PAS 84 apply with the following modifications/

Contents:

  • Foreword
  • Introduction
  • 1 Scope
  • 2 Terms, definitions and abbreviations
  • 2.1 Terms and definitions
  • 2.2 Abbreviations
  • 3 Regulatory requirements and guidance applicable to biological
  • 3.1 Key differences between the EU and the US Food and Drugs
  • 3.2 Regulatory requirements and guidance applicable to the
  • 3.3 Quality declarations for manufactured biological materials
  • 4 Evaluation criteria and mitigation of risk
  • 4.1 Evaluation criteria
  • 4.2 Mitigation of risk
  • 5 Characterization of biological materials
  • 6 Managing changes to materials
  • 6.1 The regulatory impact of changes to materials
  • 6.2 Supplier agreement considerations
  • Annexes
  • Annex A (informative) Excerpts of EC legislation that refer
  • Annex B (informative) Regulatory documents and guidance
  • Bibliography

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
BS PAS 157-2015 PDF

BS PAS 157-2015 PDF

$43.18 $86.36